BiotechTube
Home/Edwards Lifesciences/Scott B. Ullem
SB

Scott B. Ullem

Chief Financial Officer

Edwards Lifesciences

Therapeutic Areas

CardiovascularStructural Heart DiseaseHeart Failure

Edwards Lifesciences Pipeline

DrugIndicationPhase
SAPIEN X4 THVSymptomatic, severe, calcific aortic stenosisPivotal
EVOQUE Tricuspid Valve Replacement SystemSevere Tricuspid RegurgitationPivotal
PASCAL Precision SystemMitral/Tricuspid RegurgitationPost-Market
APTURE Transcatheter Shunt SystemHeart Failure (HFpEF/HFmrEF)Pivotal
SAPIEN M3 SystemMitral Valve RegurgitationEarly Feasibility/Pivotal

Leadership Team at Edwards Lifesciences

BZ
Bernard Zovighian
Chief Executive Officer
MA
Michael A. Mussallem
Executive Chairman
DC
Daveen Chopra
Corporate VP, TAVR & Surgical Structural Heart
LL
Larry L. Wood
Corporate VP, Transcatheter Mitral & Tricuspid Therapies (TMTT)
View full Edwards Lifesciences profile